Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease

Lienert, Carmen; Schawalder, Gabriela; Findling, Oliver; Kamm, Christian P.; Humpert, Sebastian; Mugglin, Anne; Mathis, Johannes; Sturzenegger, Matthias; Mattle, Heinrich P. (2013). Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. Swiss medical weekly, 143, w13783. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13783

[img]
Preview
Text
smw-2013-13783.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (406kB) | Preview

In Switzerland, the first course of intravenous steroids for treatment of episodes of demyelinating CNS disease is usually administered in an inpatient setting. We prospectively evaluated short term tolerance of treatment with special emphasis on sleep quality.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Lienert, Carmen; Findling, Oliver; Kamm, Christian Philipp; Humpert, Sebastian Jörg; Mugglin Vitiello, Anne Sabine; Mathis, Johannes; Sturzenegger, Matthias and Mattle, Heinrich

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:39

Last Modified:

26 Dec 2014 03:13

Publisher DOI:

10.4414/smw.2013.13783

PubMed ID:

23740464

Web of Science ID:

000321945100006

BORIS DOI:

10.7892/boris.15951

URI:

https://boris.unibe.ch/id/eprint/15951 (FactScience: 223457)

Actions (login required)

Edit item Edit item
Provide Feedback